Copied to clipboard!

Test study

Test study description

Type: Whole Genome Sequencing
Archive: Federated EGA Estonia Federated EGA Node

1 Dataset 2 Publications

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD50000000196	Dataset description		1

Publications	Citations
BLOCKADE OF TUMOR-INTRINSIC TGF-Β SIGNALING DRIVES HYPERPROGRESSION IN SMALL CELL LUNG CANCER. Schroeder BA, Mohindroo C, Meinhardt AL, Takahashi N, Zhang Y, Lee MJ, Sahoo S, Donahue RN, Kumar R, Nirula M, Yang Y, Rastogi S, Sato N, Lee S, Tsai YT, Zhuang S, Kazi A, Huang Y, Desai P, Nichols S, Sciuto L, Pinkiert D, Chrisafis G, Greenberg M, Biery DN, Al-Marayaty R, Yang HH, Lee MP, Schultz CW, El Meskini R, Atkinson D, Fousek K, Gulley JL, Schlom J, Sato M, Shrestha RL, Sharma AK, Jolly MK, Palena C, Wakefield LM, Thomas A. Cancer Discov 16: 2026 1529-1549	1
A stem-like chromatin program in small-cell lung cancer is associated with poor outcomes after chemoimmunotherapy. Kumar R, Desai P, El Meskini R, Mohindroo C, Benő AÁ, Atkinson D, Nirula M, Bassel L, Takahashi N, Sovacool KL, Meinhardt A, Arora M, Parmar K, Nausome D, Nichols S, Sciuto L, Swift S, Nemes K, Sharma AK, Pate N, Rajan A, Levy E, Kassin M, Aldana CF, Koparde V, Galloux M, Shreshta R, Ohler ZW, Pongor L, Thomas A. Cell Rep Med 7: 2026 103027	0

Publications

Citations

BLOCKADE OF TUMOR-INTRINSIC TGF-Β SIGNALING DRIVES HYPERPROGRESSION IN SMALL CELL LUNG CANCER.
Schroeder BA, Mohindroo C, Meinhardt AL, Takahashi N, Zhang Y, Lee MJ, Sahoo S, Donahue RN, Kumar R, Nirula M, Yang Y, Rastogi S, Sato N, Lee S, Tsai YT, Zhuang S, Kazi A, Huang Y, Desai P, Nichols S, Sciuto L, Pinkiert D, Chrisafis G, Greenberg M, Biery DN, Al-Marayaty R, Yang HH, Lee MP, Schultz CW, El Meskini R, Atkinson D, Fousek K, Gulley JL, Schlom J, Sato M, Shrestha RL, Sharma AK, Jolly MK, Palena C, Wakefield LM, Thomas A. Cancer Discov 16: 2026 1529-1549

A stem-like chromatin program in small-cell lung cancer is associated with poor outcomes after chemoimmunotherapy.
Kumar R, Desai P, El Meskini R, Mohindroo C, Benő AÁ, Atkinson D, Nirula M, Bassel L, Takahashi N, Sovacool KL, Meinhardt A, Arora M, Parmar K, Nausome D, Nichols S, Sciuto L, Swift S, Nemes K, Sharma AK, Pate N, Rajan A, Levy E, Kassin M, Aldana CF, Koparde V, Galloux M, Shreshta R, Ohler ZW, Pongor L, Thomas A. Cell Rep Med 7: 2026 103027